EB1010-treated mice showed a trend towards increased colon length, whereas Pentasa® had no effect.
← all excerpts
EB1010, a putative Christensenellaceae-derived microbial peptide, exhibits anti-inflammatory activity and therapeutic potential in ulcerative colitis.
1
—
—